News

ERA Starts Fundraising Campaign to Support MDA Summer Camps

Real estate franchiser ERA is launching the ERA MDA Summer Camp Challenge, a campaign in collaboration with the Muscular Dystrophy Association (MDA) that will gather support from brokers and agents to help 1,000 children who suffer from muscular dystrophy. This year marks the fundraiser’s third year. The challenge, announced…

PTC Extends Translarna To Siblings of DMD Trial’s Patients

Biopharmaceutical company PTC Therapeutics, Inc. is not only developing a protein restoration therapy for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD), but will also expand the drug’s current developmental trial to include siblings of the patients already enrolled in their open label PTC clinical trials. Translarna will be provided…

#CureFSHD Online Campaign Launched By FSH Society

The FSH Society, a charity organization based in Massachusetts supporting research and advocacy related to facioscapulohumeral muscular dystrophy (FSHD) has recently announced the launch of the #CureFSHD campaign. The aim of this campaign is to boost awareness and to educate people about FSHD, which is a type of…

New MDA-Supported Genetic Therapy for DMD May Work With Only One Session

Charles Gersbach, Muscular Dystrophy Association research grantee and Biomedical Engineering Professor at Duke University, has recently announced an enormous and potentially game-changing development in gene modification for young men and boys suffering from Duchenne muscular dystrophy (DMD). The results were published in Nature Communications in a…